Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.76, $1.09 better than the analyst estimate of $4.67. Revenue for the quarter came in at $9.33 billion versus the consensus estimate of $8.39 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2021 EPS of $23.37, versus the consensus of $22.19. Thermo Fisher Scientific sees FY2021 revenue of $37.1 billion, versus the consensus of $36.1 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.